Pubblicazioni

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events

2020 - EUROPEAN JOURNAL OF CANCER

Cortellini, A.; Bersanelli, M.; Santini, D.; Buti, S.; Tiseo, M.; Cannita, K.; Perrone, F.; Giusti, R.; De Tursi, M.; Zoratto, F.; Marconcini, R.; Russano, M.; Zeppola, T.; Anesi, C.; Filetti, M.; Marchetti, P.; Botticelli, A.; Gelibter, A.; De Galitiis, F.; Vitale, M. G.; Rastelli, F.; Tudini, M.; Silva, R. R.; Atzori, F.; Chiari, R.; Ricciuti, B.; De Giglio, A.; Migliorino, M. R.; Mallardo, D.; Vanella, V.; Mosillo, C.; Bracarda, S.; Rinaldi, S.; Berardi, R.; Natoli, C.; Ficorella, C.; Porzio, G.; Ascierto, P. A.

Nonalcoholic Fatty Liver Disease in Italian Children with Down Syndrome: Prevalence and Correlation with Obesity-Related Features

2017 - THE JOURNAL OF PEDIATRICS

Valentini, D; Alisi, A; di Camillo, C; Sartorelli, Mr; Crudele, A; Bartuli, A; Nobili, V; Villani, A.

The impact of nonalcoholic fatty liver disease on renal function in children with overweight/obesity

2016 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Pacifico, Lucia; Bonci, Enea; Andreoli, Gian Marco; Di Martino, Michele; Gallozzi, Alessia; De Luca, Ester; Chiesa, Claudio